Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary immunodeficiencies

R M Ten1

  • 1Division of Allergy and Outpatient Infectious Disease, Mayo Clinic Rochester, Minnesota 55905, USA.

Mayo Clinic Proceedings
|September 16, 1998
PubMed
Summary
This summary is machine-generated.

Primary immunodeficiencies are congenital immune system disorders increasing susceptibility to infections. Advances in understanding genetic defects and therapies like gene therapy offer improved patient outcomes and future treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin-2 liposomes for primary immune deficiency using the aerosol route.

International immunopharmacology·2002
Same author

Association of humoral immunodeficiency, cleidocranial dysplasia, and von Willebrand's disease in a family cluster.

The Journal of allergy and clinical immunology·2001
Same author

The signal transduction pathway of CD23 (Fc epsilon RIIb) targets I kappa B kinase.

Journal of immunology (Baltimore, Md. : 1950)·1999
Same author

The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·1999
Same author

Signal transduction pathways triggered by the FcepsilonRIIb receptor (CD23) in human monocytes lead to nuclear factor-kappaB activation.

The Journal of allergy and clinical immunology·1999
Same author

Mannose-binding lectin deficiency associated with neutrophil chemotactic unresponsiveness to C5a.

The Journal of allergy and clinical immunology·1999

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Primary immunodeficiencies (PIDs) are congenital disorders impairing immune system function.
  • PIDs result in inadequate responses to pathogens, self-antigens, and tumors, increasing risks of infection, autoimmunity, and malignancy.
  • Significant progress in understanding PID molecular mechanisms exists, yet specific genetic defects remain unidentified for certain types.

Purpose of the Study:

  • To review the current understanding of primary immunodeficiencies.
  • To highlight advances in molecular mechanisms and genetic defect identification.
  • To discuss current and future therapeutic strategies for PIDs.

Main Methods:

  • Literature review of primary immunodeficiencies.

Related Experiment Videos

  • Analysis of advances in molecular and genetic understanding.
  • Evaluation of current and emerging therapeutic interventions.

    • Main Results:

    • Substantial advances in elucidating molecular mechanisms of PIDs.
    • Identification of specific genetic defects for many, but not all, PID types.
    • Increased life expectancy for PID patients due to bone marrow transplantation and replacement therapies.

    Conclusions:

    • Gene therapy is a current and promising future treatment for specific immunodeficiencies.
    • Further understanding of genetic defects in PIDs is crucial for developing novel therapeutic strategies.
    • Improved management and outcomes for patients with primary immunodeficiencies are achievable through continued research and therapeutic innovation.